|
HS Code |
913875 |
| Product Name | Prednisone Dragon |
| Active Ingredient | Prednisone |
| Form | Tablet |
| Strength | Varies (commonly 5 mg, 10 mg, 20 mg, 50 mg) |
| Manufacturer | Dragon Pharma |
| Type | Corticosteroid |
| Route Of Administration | Oral |
| Prescription Required | Yes |
| Shelf Life | Typically 2-3 years |
| Storage Conditions | Store at room temperature, away from moisture and light |
| Primary Use | Anti-inflammatory and immunosuppressant |
| Packaging | Blister pack or bottle |
| Color | Varies depending on strength |
| Contraindications | Systemic fungal infections, hypersensitivity |
| Side Effects | Weight gain, insomnia, mood changes, increased infection risk |
As an accredited Prednisone Dragon factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Prednisone Dragon packaging features a bold red dragon logo, white background, labeled "Prednisone 20mg," contains 30 tablets per bottle. |
| Shipping | Prednisone Dragon is shipped in secure, tamper-evident packaging to maintain product integrity. Orders are dispatched via reliable carriers with tracking services. Shipments comply with chemical handling regulations, ensuring safe transit. Delivery times and conditions depend on destination, with temperature control implemented if required. Handling instructions and safety data sheets are included. |
| Storage | Prednisone Dragon should be stored at room temperature, ideally between 20°C and 25°C (68°F–77°F), away from moisture, heat, and direct light. Keep the container tightly closed and out of reach of children and pets. Avoid storing in bathrooms or humid areas. Proper storage ensures the medication remains effective and prevents contamination or accidental ingestion. |
|
Purity 99.5%: Prednisone Dragon with 99.5% purity is used in autoimmune disorder management, where enhanced immunosuppressive efficacy is achieved. Molecular Weight 358.44 g/mol: Prednisone Dragon at a molecular weight of 358.44 g/mol is used in oral tablet formulations, where precise dosing accuracy is ensured. Particle Size D90 < 10 µm: Prednisone Dragon with particle size D90 less than 10 micrometers is used in injectable suspensions, where improved bioavailability is obtained. Stability Temperature 25°C: Prednisone Dragon stable at 25°C is used in global pharmaceutical distribution, where shelf-life extension is realized. Melting Point 230°C: Prednisone Dragon with a melting point of 230°C is used in solid dosage manufacturing, where thermal process compatibility is supported. Solubility 0.3 mg/mL (water): Prednisone Dragon exhibiting solubility of 0.3 mg/mL in water is used in oral solution development, where rapid absorption is promoted. Residual Solvent < 0.01%: Prednisone Dragon with residual solvent content below 0.01% is used in parenteral preparations, where patient safety standards are met. Specific Optical Rotation +58°: Prednisone Dragon presenting a specific optical rotation of +58° is used in quality assurance laboratories, where stereochemical integrity is verified. Assay ≥ 99%: Prednisone Dragon with assay value not less than 99% is used in reference standard calibration, where analytical measurement precision is maintained. Microbial Limit < 100 CFU/g: Prednisone Dragon with microbial limit under 100 CFU per gram is used in sterile pharmaceutical production, where contamination risk is minimized. |
Competitive Prednisone Dragon prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Prednisone Dragon is one of the models we proudly produce at our dedicated chemical facility, and it continues to gain ground with clients who want reliability above all else. As long-time manufacturers in the synthetic corticosteroid space, we’ve seen trends and regulatory landscapes shift, but the core needs—purity, traceability, and stable sourcing—stand unchanged. What sets our Prednisone Dragon model apart comes down to consistency, targeted specifications, and a focus on direct feedback from the industries that actually use our products.
Every batch starts from API-grade raw material with verified sources, and we do not shortcut on the intermediates. This line follows a stringent, closed-loop synthesis process. Hydrolysis efficiency gets watched closely, and we track residual solvent levels at every stage. We set up this separate batch train for Prednisone Dragon because our partners—in pharmaceuticals, animal health, and finished-drug blending—kept asking for better particle profile and a cleaner end point. No substandard offcuts are mixed in; everything flows in a controlled, monitored cycle. Each lot runs through HPLC and GC to track assay, impurities, and solvent thresholds, as clients demand a profile suitable for both oral dosage and blending into compound formulations.
With Prednisone Dragon, we standardize the material to specific granulometry, usually favoring a fine, free-flowing crystalline powder. Volumetric density, moisture content, and optical purity remain within tight margins because that affects downstream processability—especially direct compression. We maintain a standard potency of 99.5% assay by HPLC on all released material. If a client wants a slightly coarser or micronized cut for certain types of tablets, that is feasible within the same production protocol. Residual solvents never exceed pharmacopeial minima, and we keep heavy metal and endotoxin tests current, with each COA batch referencing exact test dates and instrument trace.
Over years in manufacture, we noticed that excessive solvent retention led to caking in competitor samples. It often threw off tablet blending and filling, requiring presoaking or double milling. Our team addressed that by investing in a vacuum-drying and laminar-flow handling system at the back end of our reactor train, slashing final water and residuals down below common commercial averages. Standard microbial counts fall well below what regulatory audits look for, and every production calendar involves random in-process checks to catch drift long before final lot packaging.
Most Prednisone Dragon users want a bulk active that does not throw surprises at scale. Hospitals, compounding centers, generic manufacturers, and research teams come to us for that reason. Our experience shows that cGMP process discipline, real-time lot tracking, and open documentation save headaches in regulatory submissions. Anyone formulating tablets, topical suspensions, or veterinary blends needs that same baseline confidence.
Actual usage tells us that Prednisone Dragon performs best in solid oral dosage. Fine particle sizing (d50 below 25 microns) allows uniform blending with most tablet excipients. The surface structure stays consistent, which means you don't see variable wetting or hydrophobicity during scale-up. Long-time partners tell us our product pours clean without blowing out feeder valves. For veterinary and topical use, the fine crystalline cut dissolves fast in aqueous suspensions and oil-based base media. Long-term stability holds up in most packaging systems currently circulating, and storage life matches or beats published standards, documented by our ongoing forced-degradation and ambient condition studies.
Prednisone Dragon built its reputation on traceability and tighter reproducibility between batches. Some other market samples still show variable particle sizing or higher impurity creep after long storage. Our route—anchored on investment in analytic equipment—delivers a reproducible output lot after lot. Peers have cut costs by outsourcing key synthesis steps or skipping environmental controls, but that’s not a risk we take. Maintenance downtime for cleaning and validation in our plant slows production, but the result is a clean, cross-contaminant-free active ingredient.
We keep a dedicated team focused specifically on the Dragon line, which gives us direct feedback on blending issues, reactivity, and stability. That team stays in live contact with users—pharmacists, chemists, QA auditors—not just sales reps. Because we produce Prednisone Dragon exclusively within our own facility, we control every input and catch problems sooner than just performing a final end test. This approach also assures our clients of paperwork they can trust if regulators want to look beyond the COA to original batch records and environmental logbooks.
Every batch ties back to a full electronic batch record. Operators log every intervention; supervisors monitor each synthesis stage. Clients can, if required, audit current and previous campaign runs, tied to exact tank, operator, and day. We routinely invite pharmaceutical partners to inspect and ask questions on-site, not just rely on paperwork. In our experience, customers want real visibility—not just trust in numbers printed on labels. Each outbound shipment includes not only Certificates of Analysis but also supplementary chromatograms, microbial test results, and environmental logs to satisfy even the most detailed submission requirements.
Safety in handling comes from how we package and ship. We cannot count the number of batches ruined by poor packaging from secondary suppliers—broken seals, poorly managed desiccants, or cross-contamination. For Prednisone Dragon, the final touchpoint always takes place in a monitored, controlled environment. Drums, primary liners, and security tapes go through packaging QA, and all bags use certified low-extractable grades. Tamper-evident seals and both inner and secondary desiccant packs preserve quality from our gates to the end user, not just at the point of leaving the warehouse.
Regulators keep raising the bar: risk of impurities, cross-contaminants, or process deviations forces everyone’s hand. Prednisone Dragon was designed to meet and exceed these requirements. We use validated methods for every COA parameter, and our compliance team includes staff with backgrounds in both process chemistry and regulatory affairs. Site-wide inspections and repeat validation exercises only strengthen the chain of custody and traceability on every Dragon lot. Full audit trails remain available on file, whether the client wants trace metals, process solvent history, or operator intervention logs.
For drug master file submissions, each Prednisone Dragon lot will match the outlined profile—consistent impurity profiles, validated synthesis steps, and reproducible analytical results. Regulatory teams using our model can draw on our support team for technical documentation, validation references, and method transfer packs. We back that with real accessibility to human experts, not an automated response or third-hand information filtered through resellers.
As manufacturers, we learn from the phone calls and field visits—sometimes those conversations teach more than any journal paper. Some users encountered blending headaches with higher-vapor-content prednisone models from other plants, leading to caked agglomerates or batch failures. We tackled that by setting up routine in-process handling checks downstream of our dryers. For clients who need moisture-critical material, Prednisone Dragon delivers lot after lot.
On stability, pharmacists and warehouse managers flagged rapid photo-decomposition in generic market samples shipped in clear containers. Our packaging switch to UV-opaque liners stopped this, reducing loss in long-haul and cross-season shipments. Waste and rejection rates dropped sharply across several top-ten clients who previously encountered visible yellowing in bulk drums from outside suppliers. Clients cite that our clear, line-by-line product documentation and real-time contact make their audit processes more straightforward, saving time during submission rounds.
Many chemical manufacturers chase the lowest cost or highest volume; our focus remains on producing material that actually supports people making real pharmaceuticals and veterinary products. If a problem recurs—such as inconsistent granulation or assay drift—we review the entire process, not just the batch that failed. Our technical service team talks directly with the line operators, QC teams, and lead formulators. If we find a gap in process or field data, the Dragon line adapts based on that feedback.
We also remain committed to ongoing compatibility with new compounding and formulation technologies. Prednisone Dragon undergoes regular batch runs with updated granulation and blending excipients supplied by top global partners. Each test informs future synthesis and purification steps, enabling us to anticipate process changes before they affect clients en masse. This is not a static product; it evolves alongside user trends, new regulations, and published stability and impurity data.
In today’s world, a paper trail is not enough. The rising threat of counterfeits and relabeled bulk steroids keeps us vigilant. Every Prednisone Dragon drum location, lot runtime, and operator signature forms part of an unbroken chain. Nothing leaves our site unless it matches the digital record and on-site pack count. Random fingerprinting of bulk material and secondary chemical markers on packaging provide another security layer for those who require verification beyond regular documentation.
We refuse to gamble with ingredients drawn from unknown or unvetted sources. All source chemicals, synthesis aids, and solvents meet strict voluntary vendor verification. If a partner’s audit reveals a gap in our supply chain, we work immediately to close it—even if that means switching suppliers or taking a financial hit to guarantee uninterrupted, validated material.
Our teams review every note from finished-dose manufacturers and compounders who rely on Prednisone Dragon. It’s not unusual for us to check back on process changes or lab variation weeks or months after delivery. We want more than a sale; we want ongoing dialogue about performance, application headaches, or unexpected strengths. That loop informs our plant design, scheduling, and investment in next-gen analytic and batch-lot management tools.
We schedule regular root-cause investigations—even on complaints that turn out to stem from the customer’s environment, not our plant. This level of attention improves our own processes and reinforces the expectation that every Dragon lot will mirror the next. It’s slow at times, but it pays off in complaint-free shipments, stable client portfolios, and fewer emergency calls from downstream drug manufacturers.
After decades on the supply side, we’ve heard all kinds of claims about prednisone batches from traders or resellers. Many offer slight discounts, attractive terms, or easy import documentation—but cannot guarantee process details or lot history. By maintaining full control inside our own plant and never subcontracting core steps, we ensure our clients do not inherit avoidable risks.
Our senior operators learn every change in yield, vapor emission, and odor—often spotting a potential variation before the final tests run. With third-party suppliers, teams lose that continuity. This lack of oversight means some market prednisone batches reach end users with unwanted solvent loads, unknown origins, or mismatched labeling. We sidestep that with in-house expertise at every step, from purchase order to sealed drum. Our batch records show every additive, integration timepoint, and operator check; no detail vanishes into a black box at a distant toll plant.
Global demand for reliable corticosteroids will keep rising as health systems expand and animal care standards grow stricter. Regulations will tighten, and scrutiny over source material only gets more intense. By keeping all key steps in-house and guarding traceability from source to shipment, Prednisone Dragon already matches future market and compliance needs.
Our team’s knowledge base grows with each cycle, from chemical synthesis to market feedback. We never stop looking for data on stability, process chemistry advances, or user practice changes—whether that comes from published journals, partner trials, or direct client calls. In each case, the insights apply immediately to the next manufacturing run. The Drug model isn’t frozen in time; it picks up the best from what’s come before and what’s needed tomorrow.
The strongest feedback we receive does not always come through official audits. It often comes in the form of a midnight call after a tricky batch or a request for spot analysis following an unexpected blip in a formulation line. We stay available, not only during regular hours but whenever our expertise can make a difference for a partner in need. Our lines remain open to receiving performance reports—positive or otherwise—because each one teaches us where to make the next meaningful improvement.
Long-standing clients say our willingness to troubleshoot alongside them, not just push product, sets our Prednisone Dragon line apart. Whether the issue concerns granular flow in high-speed tablet press fills, reactivity with new excipients, or batch-specific traceability, our team digs for an answer directly. That hands-on attention means our material stays ready for the jobs that matter most—be it hospital supply, compounding under tight timelines, or new pharmaceutical breakthroughs.
Prednisone Dragon represents decades of experience, tough lessons learned, and a willingness to invest where it matters. All the controls in place—analytic, process, packaging, and compliance—come from living in the real world of chemical manufacture, not outsourcing the job. It’s built by people who take direct pride in their product, who understand what the next audit, regulatory update, or field report might mean for a partner’s operation. We manufacture—and stand behind—Prednisone Dragon as more than a product: it’s the result of deep commitment to long-term trust and real accountability.